Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients
暂无分享,去创建一个
C. Ding | Leilei Wu | Shengnan Jin | Yixue Li | Songwen Zhou | Chao Li | Yu-chen Bao | Qin‐Fang Deng | Jialu Li | B. Xie | Xian-xiu Ji | Li Feng | Qiyu Fang | Chunming Ding